Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018
Serum ECP levels do not correlate with degree of bronchial hyperresponsiveness in patients with cough variant asthma Source: Eur Respir J 2005; 26: Suppl. 49, 584s Year: 2005
The value of the serum ECP (eosinophil cationic protein) level for monitoring the treatment of allergic bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 268s Year: 2001
Serum levels of interleukin-18 in patients affected by allergic bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 30s Year: 2002
Does eosinophil cationic protein (ECP) predict asthma outcome and response to treatment in asthmatic patients? Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Serum high sensitivity C-reactive protein can distinguish cough-variant and bronchial asthma Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Surfactant protein-A serum level is associated with disease control and hospitalisation in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010
Bronchial inflammation without asthma symptoms, relation to low neutrophil activity in serum Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002
Inhibiting effect of influenza vaccinations on serum eotaxin level in patients with allergic bronchial asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 134s Year: 2004
Association of sputum chitinase like protein levels with pathophysiology and neutrophilic airway inflammation in asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008
ECP in saliva: marker of disease activity in mild to moderate pediatric asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
Serum concentration of C-reactive protein is not a good marker of bronchial hyperreactivity Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007
Plasma eotaxin level in children with acute bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 314s Year: 2003
FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
Role of sputum eosinophil levels in the assessment of asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004
Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Source: Eur Respir J 2003; 22: 484-490 Year: 2003
Analysis of IgE and C-reactive protein as possible predictors of exacerbation patients with asthma Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011
Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016